Cancer Diagnostics Market
                     Cancer Diagnostics Market
Global Forecast to 2026
Cancer Diagnostics Market 
is expected to reach 
USD 26.6 billion by 2026
 Growing at a 
CAGR of  11.5% (2021 – 2026)
CANCER DIAGNOSTICS MARKET 
MARKET OPPORTUNITY 
CAGR of OVER NEXT 5 YEARS KEY MARKET PLAYERS BY INSTRUMENTS 
2021 – 2026 26.6 b

CAGR Danaher Corporation (US)17.2 b  Pathology Becton
Instruments
 Dickinson and Company (US)

 Bio-Rad Laboratories, Inc. (US.) Imaging 
 InstrumentsF. Hoffman-La Roche AG (Switzerland)
2021 2026
 QIAGEN N.V. (Netherlands) Biopsy
North America BY APPLICATION
Europe
Asia Pacific
Rest of the World Breast Cancer
Lung Cancer
According to market research report "Cancer Diagnostics Market by Product (Consumables (Anitibodies, 
Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), 
Application (Breast Cancer, Lung Cancer), End User (Hospitals) - Global Forecasts to 2026", published by 
MarketsandMarkets™, is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 
11.5%. Growth of the cancer diagnostics market is driven mainly by increasing incidence of cancer and growth 
in the number of private diagnostic laboratories.
Key Players:
Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US.), F. Hoffman-La 
Roche AG (Switzerland), QIAGEN N.V. (Netherlands), Fujifilm Corporation (Japan), Aglient Technologies (US) and 
Thermo Fisher Scientific Inc. (US) etc.
Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121
Browse in-depth TOC on "Cancer Diagnostics Market"
300 - Tables
48 - Figures
280 – Pages
Consumables accounted for the larger share of the cancer diagnostics market in 2020
Based on the product, the cancer diagnostics industry is segmented into consumables and instruments. In 2020, 
the instruments segment accounted for the larger share of the cancer diagnostics market. The large share of this 
segment can be attributed to the increasing incidence of cancer and increasing number of cancer diagnostics test.
By technology, the IVD testing segment accounted for the largest industry share in 2020
Based on the technology, the cancer diagnostics market is segmented into IVD testing, imaging based technique 
and biopsy technique. The IVD testing segment accounted for the largest market share in 2020. The increasing 
incidence of cancer and technological advancement are major driving factors for this market.
Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121
Hospitals are the largest end-users of the cancer diagnostics market
Based on end-users, the cancer diagnostics market is segmented into hospitals and diagnostic 
laboratories. The hospitals segment accounted for the largest market share in 2020 due to the rising 
number of in-house diagnostic procedures performed in hospitals, growing awareness regarding 
early diagnosis, and the availability of reimbursements.
North America dominates the global Lung cancer diagnostics market
The cancer diagnostics market is segmented into four major regional segments, namely, North 
America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the 
largest share of the cancer diagnostics market. The large share of North America can be attributed 
to factors such as the increasing incidences of cancer, growing awareness early diagnosis and 
technological advancement.
About MarketsandMarkets™ 
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which 
will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide 
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries 
worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the 
"Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new 
opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of 
incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 
MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) 
annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 
companies this year for their revenue planning and help them take their innovations/disruptions early to the 
market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects 
over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market 
sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
View Full Report - https://www.marketsandmarkets.com/Market-Reports/cancer-diagnostics-
market-186559121.html